Signs Strategic Cooperation Agreement with Nanjing Transformation Institute of Molecular Medicine, Peking University

On May 20, 2020, Jiangsu RealTop Biotechnology Co., Ltd. and the Nanjing Institute of Molecular Medicine of Peking University signed the "One-time Storage and Distribution System and Supporting Product Development" Strategic Cooperation Agreement.

Nanjing Institute of Transformation of Molecular Medicine of Peking University is a scientific research team of the Institute of Molecular Medicine of Peking University. Relying on the policy of new R & D institutions in Nanjing, Nanjing Jiangbei New District has established a scientific and technological achievements transformation center. The center is equipped with "brain garden" and "medicine garden" two major plates, with brain imaging platform, pathology platform, drug screening platform, biochemical molecular platform, data center, animal center, machine processing platform, etc., with perfect equipment and research and development team.

strategic cooperation agreement will help our company to make full use of the advantages of university technology and human resources through school-enterprise cooperation, promote the technological progress of enterprises, and comprehensively improve the scientific and technological content of project development and the added value of products.

Figure 1: Nanjing Translational Research Institute of Molecular Medicine, Peking University

Figure 2: Transformation Institute Machine Plus Platform